21 July 2022: Clinical Research
Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
Jun Li BCDE , Jing Wang ABCEF*DOI: 10.12659/MSM.935326
Med Sci Monit 2022; 28:e935326
Table 1 Correlation between clinicopathologic parameters and sTIM-3 concentration.
| Characteristics | Training cohort | Validation cohort | |||||
|---|---|---|---|---|---|---|---|
| sTIM-3 | P | sTIM-3 | P | ||||
| Low | High | Low | High | ||||
| Gender | Female | 4 | 6 | 0.488 | 5 | 5 | 0.628 |
| Male | 51 | 48 | 28 | 20 | |||
| Age (y) | ≤50 | 20 | 23 | 0.506 | 20 | 13 | 0.512 |
| >50 | 35 | 31 | 13 | 12 | |||
| ALT (U/L) | ≤40 | 41 | 27 | 0.937 | 20 | 12 | 0.339 |
| >40 | 14 | 27 | 13 | 13 | |||
| Tumor size (cm) | ≤5 | 19 | 12 | 0.008 | 22 | 12 | 0.153 |
| >5 | 36 | 42 | 11 | 13 | |||
| PVTT | Absent | 36 | 36 | 0.894 | 21 | 16 | 0.977 |
| Present | 19 | 18 | 12 | 9 | |||